Biodegradable Materials and Metallic Implants—A Review
Source abstract
Abstract
Recent progress made in biomaterials and their clinical applications is well known. In the last five decades, great advances have been made in the field of biomaterials, including ceramics, glasses, polymers, composites, glass-ceramics and metal alloys. A variety of bioimplants are currently used in either one of the aforesaid forms. Some of these materials are designed to degrade or to be resorbed inside the body rather than removing the implant after its function is served. Many properties such as mechanical properties, non-toxicity, surface modification, degradation rate, biocompatibility, and corrosion rate and scaffold design are taken into consideration. The current review focuses on state-of-the-art biodegradable bioceramics, polymers, metal alloys and a few implants that employ bioresorbable/biodegradable materials. The essential functions, properties and their critical factors are discussed in detail, in addition to their challenges to be overcome.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Magnesium Alloys: Properties and Applications · Titanium Alloys Microstructure and Properties
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
CNRS, Univ. Bordeaux, ICMCB, UPR 9048, F-33600 Pessac, France
Rudolfs Cimdins Riga Biomaterials Innovations and Development Centre of RTU, Institute of General Chemical Engineering, Faculty of Materials Science and Applied Chemistry, Riga Technical University, Pulka 3, LV-1007 Riga, Latvia
Funding
European Social Fund
References (100+)
Show source-provided references
1. Cardiac Pacemakers and Defibrillators10.1111/j.1399-6576.1962.tb00128.x ↗
2. Engineered 3D bioimplants using elastomeric scaffold, self-assembling peptide hydrogel, and adipose tissue-derived progenitor cells for cardiac regeneration
3. Rapid evaluation of the durability of cortical neural implants using accelerated aging with reactive oxygen species10.1088/1741-2560/12/2/026003 ↗
4. Sensory innervation around immediately vs. delayed loaded implants: A pilot study10.1038/ijos.2014.53 ↗
5. Bagga, C., Erbe, E.M., Murphy, J.P., Freid, J.M., and Pomrink, G.J. (2014). Bioactive Spinal Implants and Method of Manufacture Thereof. (8,715,353), U.S. Patent.
6. Thirst driving and suppressing signals encoded by distinct neural populations in the brain10.1038/nature14108 ↗
7. Substrate modulus of 3D-printed scaffolds regulates the regenerative response in subcutaneous implants through the macrophage phenotype and Wnt signaling10.1016/j.biomaterials.2015.09.005 ↗
8. Systematic review on success of narrow-diameter dental implants10.11607/jomi.2014suppl.g1.3 ↗
9. Imaging of cosmetic plastic procedures and implants in the body and their potential complications10.2214/AJR.14.13516 ↗
10. Microstructural and mechanical study of zirconia-hydroxyapatite (ZH) composite ceramics for biomedical applications10.1016/S0266-3538(00)00222-0 ↗
11. Bioceramics—Current status and future trends10.4028/www.scientific.net/MSF.293.99 ↗
12. Hench, L.L., and Wilson, J. (1993). An Introduction to Bioceramics, World Scientific. [2nd ed.].10.1142/2028 ↗
13. Bioresorbable devices made of forged composites of hydroxyapatite (HA) particles and poly-l-lactide (PLLA): Part I. Basic characteristics10.1016/S0142-9612(98)00241-5 ↗
14. Bioactive materials10.1016/0272-8842(95)00126-3 ↗
15. Randomized prospective study of ACL reconstruction with interference screw fixation in patellar tendon autografts versus femoral metal plate suspension and tibial post fixation in hamstring tendon autografts: 5-year clinical and radiological follow-up results10.1007/s00167-006-0059-0 ↗
16. Comparison of metal release from various metallic biomaterials in vitro10.1016/j.biomaterials.2004.02.005 ↗
17. Biodegradable implants in sports medicine: The biological base10.1016/S0749-8063(00)90055-0 ↗
18. Degradable and bioresorbable polymers in surgery and in pharmacology: Beliefs and facts10.1007/s10856-008-3581-4 ↗
19. Recent advances on the development of magnesium alloys for biodegradable implants10.1016/j.actbio.2014.07.005 ↗
20. Design strategy for biodegradable Fe-based alloys for medical applications10.1016/j.actbio.2009.07.039 ↗
21. Some basic relationships between density values in cancellous and cortical bone10.1016/j.jbiomech.2008.03.025 ↗
22. Bone-grafting and bone-graft substitutes10.2106/00004623-200203000-00020 ↗
23. Scaffold design and fabrication technologies for engineering tissues—State of the art and future perspectives10.1163/156856201744489 ↗
24. Biphasic calcium phosphate bioceramics: Preparation, properties and applications10.1023/A:1022872421333 ↗
25. Hydroxylation of dental zirconia surfaces: Characterization and bonding potential10.1002/jbm.b.31126 ↗
26. Low-aspect ratio nanopatterns on bioinert alumina influence the response and morphology of osteoblast-like cells10.1016/j.biomaterials.2015.05.026 ↗
27. Calcium orthophosphates in medicine: From ceramics to calcium phosphate cements10.1016/S0020-1383(00)80022-4 ↗
28. Clinical applications of calcium phosphate biomaterials: A review10.1016/0272-8842(93)90050-2 ↗
29. Resorbable calcium phosphate bone substitute10.1002/(SICI)1097-4636(199824)43:4<399::AID-JBM7>3.0.CO;2-J ↗
30. Resorption of apatite-wollastonite containing glass-ceramic and beta-tricalcium phosphate in vivo
31. Ionic substitutions in calcium phosphates synthesized at low temperature10.1016/j.actbio.2009.12.041 ↗
32. Zinc-substituted hydroxyapatite: A biomaterial with enhanced bioactivity and antibacterial properties10.1007/s10856-012-4817-x ↗
33. Manganese in precipitated hydroxyapatites10.1002/ejic.200390188 ↗
34. Resorbable dicalcium phosphate bone substitutes prepared by 3D powder printing10.1002/adfm.200700019 ↗
35. The effect of autoclaving on the physical and biological properties of dicalcium phosphate dihydrate bioceramics: Brushite vs. monetite10.1016/j.actbio.2012.04.025 ↗
36. Bioceramics for drug delivery10.1016/j.actamat.2012.10.039 ↗
37. Transforming growth factor-6 stimulates bone ongrowth: Hydroxyapatite-coated implants studied in dogs10.3109/17453679608997766 ↗
38. A bioactive sol-gel glass implant for in vivo gentamicin release. Experimental model in Rabbit10.1002/jor.20064 ↗
39. Hard-templating synthesis of a novel rod-like nanoporous calcium phosphate bioceramics and their capacity as antibiotic carriers10.1016/j.matchemphys.2007.02.069 ↗
40. Efficacy of gentamycin-impregnated resorbable hydroxyapatite cement in treating osteomyelitis in a rat model10.1097/00005131-199902000-00006 ↗
41. Calcium phosphate bone cements for clinical applications. Part I: Solution chemistry10.1023/A:1008937507714 ↗
42. Biodegradable polymeric materials10.1002/adma.19960080406 ↗
43. Biodegradable synthetic polymers for tissue engineering10.22203/eCM.v005a01 ↗
44. Injectable biodegradable polymer composites based on poly (propylene fumarate) crosslinked with poly (ethylene glycol)-dimethacrylate10.1016/S0142-9612(00)00106-X ↗
45. Self-concentrations and effective glass transition temperatures in polymer blends10.1021/ma9921706 ↗
46. Biodegradable bone repair materials: Synthetic polymers and ceramics10.1097/00003086-198606000-00046 ↗
47. Synthetic biodegradable polymers as orthopedic devices10.1016/S0142-9612(00)00101-0 ↗
48. Molecular modeling study of the resistance of PLA to hydrolysis based on the blending of PLLA and PDLA10.1016/j.polymer.2006.05.002 ↗
49. The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis10.1016/j.biomaterials.2004.01.066 ↗
50. Biodegradable polymers as biomaterials10.1163/156856295X00175 ↗
51. Poly (para-dioxanone) and poly (l-lactic acid) blends: Thermal, mechanical, and morphological properties10.1002/app.11984 ↗
52. Biodegradable materials for bone repairs: A review10.1016/j.jmst.2013.03.002 ↗
53. Bioabsorbable Implant Material Review10.1053/j.otsm.2004.07.015 ↗
54. The biodegradation of polymers: Recent results
55. Biodegradation of polymers
56. Biodegradation of Polymers. Journal of Siberian Federal University
57. Peri-implant inflammation defined by the implant-abutment interface10.1177/154405910608500515 ↗
58. Degradable biomaterials based on magnesium corrosion10.1016/j.cossms.2009.04.001 ↗
59. Evaluation of peri-implant bone loss around platform-switched implants
60. Biodegradable materials for bone repair and tissue engineering applications10.3390/ma8095273 ↗
61. Comparative evaluation of polycyanoacrylates10.1016/j.actbio.2016.11.011 ↗
62. In Vitro Controlled Drug Release of Anticancer Drugs Deguelin and Cisplatin by Lauric Acid Derived Polyanhydride as Carrier
63. Poly (amino acid)-based fibrous scaffolds modified with surface-pendant peptides for cartilage tissue engineering10.1002/term.1982 ↗
64. A review on biodegradable materials for cardiovascular stent application10.1007/s11706-016-0344-x ↗
65. Baillargeon, A.L., and Mequanint, K. (2014). Biodegradable polyphosphazene biomaterials for tissue engineering and delivery of therapeutics. BioMed Res. Int., 2014, Available online: https://www.hindawi.com/journals/bmri/2014/761373/.10.1155/2014/761373 ↗
66. Diez-Pascual, A.M. (2017). Tissue Engineering Bionanocomposites Based on Poly (propylene fumarate). Polymers, 9.10.3390/polym9070260 ↗
67. Polylactic acid (PLA) controlled delivery carriers for biomedical applications10.1016/j.addr.2016.06.018 ↗
68. An overview of poly (lactic-co-glycolic) acid (PLGA)-based biomaterials for bone tissue engineering10.3390/ijms15033640 ↗
69. Advances in drug delivery systems based on synthetic poly (hydroxybutyrate)(co) polymers10.1016/j.progpolymsci.2017.05.002 ↗
70. Electrophoretic deposition of antibiotic loaded PHBV microsphere-alginate composite coating with controlled delivery potential10.1016/j.colsurfb.2015.04.009 ↗
71. Drug delivery system based on cyclodextrin-naproxen inclusion complex incorporated in electrospun polycaprolactone nanofibers10.1016/j.colsurfb.2013.11.021 ↗
72. Surgical-site infection after abdominal wall closure with triclosan-impregnated polydioxanone sutures: Results of a randomized clinical pathway facilitated trial (NCT00998907)10.1016/j.surg.2013.04.011 ↗
73. First human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence10.1016/j.jvsv.2012.09.010 ↗
74. Degradation and Stabilization of Polycyanoacrylates10.1002/(SICI)1099-0518(19991215)37:24<4570::AID-POLA14>3.0.CO;2-# ↗
75. Novel Magnesium alloys developed for biomedical application: A review10.1016/j.jmst.2013.02.005 ↗
76. In vitro and in vivo corrosion measurements of magnesium alloys10.1016/j.biomaterials.2005.07.037 ↗
77. Mechanical properties and microstructure of magnesium-aluminum based alloys containing strontium10.2320/matertrans.MOV2007315 ↗
78. Mechanical Properties of Magnesium-Rare Earth Alloy Systems: A Review10.3390/met5010001 ↗
79. Aluminium-induced acute neurotoxicity in rats: Treatment with aqueous extract of Arthrophytum (Hammada scoparia)10.1016/j.joad.2016.08.028 ↗
80. In vivo evaluation of Mg–6Zn and titanium alloys on collagen metabolism in the healing of intestinal anastomosis10.1038/srep44919 ↗
81. A review on magnesium alloys as biodegradable materials10.1007/s11706-010-0024-1 ↗
82. Characterization of strengthening precipitate phases in a Mg–Zn alloy10.1016/j.scriptamat.2007.01.006 ↗
83. The development of binary Mg–Ca alloys for use as biodegradable materials within bone10.1016/j.biomaterials.2007.12.021 ↗
84. Microstructure, mechanical properties and bio-corrosion properties of Mg–Si(–Ca, Zn) alloy for biomedical application10.1016/j.actbio.2009.11.024 ↗
85. Understanding magnesium corrosion—A framework for improved alloy performance10.1002/adem.200310405 ↗
86. Corrosion mechanisms of magnesium alloys10.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N ↗
87. Current research progress in grain refinement of cast magnesium alloys: A review article10.1016/j.jallcom.2014.09.061 ↗
88. Lee, Y.C., Dahle, A.K., and StJohn, D.H. (2016). Grain refinement of Magnesium. Essential Readings in Magnesium Technology, Springer.10.1007/978-3-319-48099-2_41 ↗
89. Novel biocompatible magnesium alloys design with nutrient alloying elements Si, Ca and Sr: Structure and properties characterization10.1016/j.mseb.2016.08.005 ↗
90. He, C., Bin, S., Wu, P., Gao, C., Feng, P., Yang, Y., Liu, L., Zhou, Y., Zhao, M., and Yang, S. (2017). Microstructure Evolution and Biodegradation Behavior of Laser Rapid Solidified Mg–Al–Zn Alloy. Metals, 7.10.3390/met7030105 ↗
91. Long-term clinical study and multiscale analysis of in vivo biodegradation mechanism of Mg alloy10.1073/pnas.1518238113 ↗
92. Research on an Mg–Zn alloy as a degradable biomaterial10.1016/j.actbio.2009.06.028 ↗
93. Effects of Ca on the formation of LPSO phase and mechanical properties of Mg-Zn-Y-Mn alloy10.1016/j.msea.2015.09.046 ↗
94. Surface modification of magnesium alloys developed for bioabsorbable orthopedic implants: A general review10.1002/jbm.b.32707 ↗
95. Biocompatibility of bio-Mg-Zn alloy within bone with heart, liver, kidney and spleen10.1007/s11434-009-0080-z ↗
96. High strength low alloy (HSLA) Mg-Zn-Ca alloys with excellent biodegradation performance10.1007/s11837-014-0875-5 ↗
97. Assessing the degradation performance of ultrahigh-purity magnesium in vitro ad in vivo10.1016/j.corsci.2014.09.008 ↗
98. Biodegradable magnesium alloys for orthopaedic applications: A review on corrosion, biocompatibility and surface modifications10.1016/j.msec.2016.06.020 ↗
99. Development and microstructural characterizations of Mg-Zn-Ca alloys for biomedical applications10.1016/j.mseb.2011.06.008 ↗
100. Calcium orthophosphate coatings on magnesium and its biodegradable alloys10.1016/j.actbio.2014.02.026 ↗